21 results match your criteria: "New York Eye Surgery Center[Affiliation]"
Curr Opin Ophthalmol
January 2025
New York Eye Surgery Center, New York City, New York, USA.
Purpose Of Review: This review highlights new Federal Drug Administration (FDA) approved glaucoma treatments to familiarize providers with immediately available options.
Recent Findings: New FDA-approved treatments include the bimatoprost implant, travoprost implant, direct selective laser trabeculoplasty (DSLT), and ocular pressure adjusting pump. The bimatoprost implant is approved for a single administration with effects lasting for about 1 year, as opposed to the nearly 3-year effect for the travoprost implant.
Ocul Surf
October 2024
Paris-Saclay, Versailles Saint Quentin University, Paris, Île-de-France, France; Centre Hospitalier National D'Ophtalmologie des Quinze-Vingts, IHU ForeSight, Paris, Île-de-France, France.
Transl Vis Sci Technol
March 2024
North Bay Eye Associates, Petaluma, CA, USA.
Ophthalmol Ther
December 2023
Minnesota Eye Consultants, University of Minnesota, Minneapolis, MN, USA.
Topical glaucoma medications are effective and safe, but they have numerous well-documented limitations that diminish their long-term utility and sustainability. These limitations can include high rates of nonadherence (with associated glaucoma progression), concerning side effects, inconsistent circadian intraocular pressure (IOP) control, complex dosing regimens, difficulty with self-administration, costs, and decreased quality of life. Despite these limitations, topical medications traditionally have been first-line in the glaucoma treatment algorithm, as no other minimally invasive treatment alternatives existed.
View Article and Find Full Text PDFJ Curr Ophthalmol
November 2022
Triangle Eye Consultants, Raleigh, NC, USA.
Purpose: To explore how ophthalmologist productivity, wellness, and musculoskeletal (MSK) symptoms are affected by heads-up display (HUD) use.
Methods: A digital survey was emailed to the United States ophthalmologists. Questions covered topics including MSK health, surgical output, work hours, wellness hours, and factors related to HUD use.
Ophthalmol Ther
December 2022
Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY, USA.
Introduction: This study compared the safety and efficacy of sutureless Ahmed glaucoma valve surgery (AGV standalone) to sutureless AGV plus cataract surgery (AGV-CEIOL) in Black or Hispanic patients.
Methods: Records from Black or non-white Hispanic patients who received either AGV standalone or AGV-CEIOL from 2014 to 2019 at a Bronx, New York practice were reviewed. All surgeries were performed using a sutureless technique with Tisseel fibrin glue.
Graefes Arch Clin Exp Ophthalmol
November 2022
Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY, USA.
Purpose: To determine factors associated with vision loss 1 year after Ahmed glaucoma valve (AGV) surgery in Black or Hispanic patients, who bear disproportionate glaucoma burdens yet have been underrepresented in pivotal trials.
Methods: This retrospective study included Black or Hispanic patients who received AGVs standalone or combined with phacoemulsification and/or cyclodestructive lasers. Univariate and multivariate generalized estimating equations evaluated the effects of baseline, surgical, and postoperative factors on vision loss of two Snellen lines or more at the 1-year follow-up visit.
Clin Ophthalmol
June 2022
EyePoint Pharmaceuticals, Watertown, MA, USA.
Purpose: To evaluate dexamethasone intraocular suspension 9% (intraocular DXM) in real-world clinical use to manage inflammation associated with cataract surgery.
Setting: Patients who underwent cataract surgery and received intraocular DXM at 22 outpatient eye surgery centers in the US.
Design: Retrospective, observational chart review.
Clin Ophthalmol
December 2021
Triangle Eye Consultants, Cary, NC, USA.
Purpose: To quantify features of musculoskeletal (MSK) complaints among US ophthalmologists and analyze factors related to symptom severity.
Methods: Cornea, glaucoma, retina, and comprehensive practitioners were invited to complete a web-based survey via email. Data on demographics, practice and procedural volumes, wellness activities, job stress, MSK health, the Total Disability Index (TDI), and ergonomics were collected.
Clin Ophthalmol
January 2021
Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY, USA.
Purpose: To compare the safety and efficacy of two different techniques for implantation of the XEN Gel Stent, a minimally invasive surgical device for the treatment of refractory glaucoma.
Methods: A retrospective chart review of eyes that received ab interno or ab externo XEN Gel Stent placement from February 2017 to October 2019 was conducted. A single surgeon (NMR) performed all operations.
Graefes Arch Clin Exp Ophthalmol
February 2021
Mount Sinai Health System, New York, NY, USA.
Purpose: To assess whether an association exists between pretreatment corneal hysteresis (CH) and the magnitude of intraocular pressure (IOP) and medication burden reduction following microinvasive glaucoma surgery (MIGS).
Methods: Retrospective chart review of 84 eyes from 57 patients with CH measurements who underwent trabecular meshwork MIGS in a glaucoma practice in New York City with follow-up visits at 3-6 and 9-12 months. MIGS included canaloplasty, goniotomy, microbypass stents, or a combination thereof.
Clin Ophthalmol
August 2020
Arizona Eye Consultants, Tucson, AZ, USA.
Purpose: To evaluate intraocular pressure (IOP) reduction measured by a Goldmann applanation tonometer (GAT) prism and a modified surface Goldmann (CATS) prism with the institution of a topical prostaglandin analog (PGA) or alternatively a topical beta blocker.
Design: Prospective, open-label, randomized, controlled, and reference device comparison.
Methods: Thirty-six (36) treatment naïve glaucoma patients (72 eyes) were randomized equally to treatment with latanoprost 0.
J Cataract Refract Surg
October 2020
From the Oklahoma Eye Surgeons, PLLC (Sarkisian), Oklahoma City, Oklahoma, Department of Ophthalmology, Mt. Sinai School of Medicine (Radcliffe), New York Eye and Ear Infirmary (Radcliffe), New York Eye Surgery Center (Radcliffe), New York City, New York; University of Montreal (Harasymowycz), Montreal, Canada; Bellevue Ophthalmology Clinics (Harasymowycz), New York City, New York, Vold Vision (Vold), Fayetteville, Arkansas, Department of Ophthalmology, Cook County Health (Patrianakos), Chicago, Illinois, Department of Ophthalmology, University of Michigan (Zhang), Ann Arbor, Michigan, Department of Ophthalmology, Glaucoma Division, Duke Eye Center (Herndon), Durham, North Carolina, Sacramento Eye Consultants (Brubaker), Sacramento, California, Department of Ophthalmology, Thomas Jefferson University School of Medicine (Moster), Glaucoma Service, Wills Eye Hospital (Moster), Philadelphia, Pennsylvania, Doheny Eye Institute, David Geffen School of Medicine (Francis), University of California Los Angeles, Los Angeles, California.
Minimally invasive glaucoma surgery (MIGS) has become a reliable standard of care for the treatment of glaucoma when combined with cataract surgery. This review describes the MIGS procedures currently combined with and without cataract surgery with a focus on visual outcomes based on the literature and the experience of the ASCRS Glaucoma Clinical Committee.
View Article and Find Full Text PDFClin Ophthalmol
December 2018
Weill Cornell Medical College, New York, NY, USA,
Purpose: To evaluate the safety and efficacy profile of a sutureless procedure for drainage valve implantation with combined cataract removal and/or endoscopic cyclophotocoagulation (ECP).
Materials And Methods: A retrospective case series study of consecutive surgeries for Ahmed glaucoma valve (AGV; New World Medical) implantation in a 1-year period was analyzed. The surgery was performed using a Tisseel fibrin sealant (Baxter Healthcare Corporation) in place of sutures.
Adv Ther
September 2018
Vance Thompson Vision, Sioux Falls, SD, USA.
Introduction: To describe the 12-month efficacy and safety of goniotomy performed using the Kahook Dual Blade (KDB) in combination with cataract surgery in eyes with medically treated open-angle glaucoma (OAG).
Methods: This was a prospective, interventional case series conducted at seven centers in North America. Consecutive patients with medically treated OAG and visually significant cataract underwent phacoemulsification combined with goniotomy (PE + goniotomy) using KDB.
J Cataract Refract Surg
September 2017
From Vance Thompson Vision (Greenwood, Berdahl), Sioux Falls, South Dakota, the University of Colorado School of Medicine (Seibold), Aurora, Colorado, the New York Eye Surgery Center (Radcliffe), New York, New York, the Mayo Clinic (Dorairaj), Jacksonville and the Eye Institute (Darlington), Melbourne, Florida, the University of Illinois (Aref, Román), Chicago, Illinois, New World Medical, Inc. (Abdullah, Bahjri), Rancho Cucamonga, California, and B Through C, LLC (Jasek), Burleson, Texas, USA; Asociación para Evitar la Ceguera (Lazcano-Gomez), Mexico City, Mexico.
Purpose: To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of a single-use dual blade (Kahook) in patients with mild to end-stage glaucoma.
Setting: International multicenter ophthalmic care centers.
Design: Prospective interventional case series.
J Cataract Refract Surg
September 1990
New York Eye Surgery Center, Bronx 10469.
We report two cases in which hydrogel lens implants have dislocated posteriorly into the vitreous body following YAG laser capsulotomy. These lenses were placed in the bag in conjunction with a capsulorhexis. A comparison with our results using silicone and poly(methyl methacrylate) implants indicates that this phenomenon has occurred only with hydrogel implants.
View Article and Find Full Text PDFJ Cataract Refract Surg
March 1990
New York Eye Surgery Center, Bronx 10469.
In recent years bimanual phacoemulsification has become an increasingly popular method of cataract extraction. We describe a new spatula designed to manipulate and protect the posterior capsule safely during phacoemulsification. In addition, this spatula can be used to facilitate irrigation/aspiration.
View Article and Find Full Text PDFJ Cataract Refract Surg
May 1988
New York Eye Surgery Center, Bronx 10469.
This study is a comparison of endothelial cell loss seen by two surgeons using the same surgical technique (posterior chamber phacoemulsification) with posterior chamber implants of two different materials (silicone and polymethylmethacrylate [PMMA]). One hundred four silicone lenses were implanted following phacoemulsification and compared with 160 PMMA lenses implanted during the same period. A significant feature of these procedures was the incidence of endothelial cell loss of greater than 1,200 cells/mm2.
View Article and Find Full Text PDFJ Cataract Refract Surg
May 1988
New York Eye Surgery Center, Bronx 10469.
Initial clinical studies with 117 silicone implants are presented. Techniques of implantation including flat insertion, bar-style folder, and syringe-style inserter are discussed. Visual results were compared with results after polymethylmethacrylate (PMMA) lens implantation and were equal if not better.
View Article and Find Full Text PDFJ Cataract Refract Surg
September 1987
New York Eye Surgery Center, Bronx 10469.
The clinical experience of two surgeons performing Nd:YAG laser anterior vitreolysis to disrupt vitreous strands adherent to surgical wounds with and without pupillary distortions and/or cystoid macular edema is presented. We describe our technique. The results indicate that vision improved in 50% of the cases, with visual acuity improving from 20/40 or better in three of 20 eyes preoperatively to 11 of 20 eyes postoperatively.
View Article and Find Full Text PDF